Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: lim....

RE: lim....

posted on Nov 21, 2005 03:41PM
PTSC ,JW in particular, wanted to benchmark ``Inflame`` but as far as I can recall they never mentioned doing so until the PR goof. Was that supposed to be their next PR or does Pohl not recall whether they benchmarked Ignite or Inflame? Anyone else recall if we benchmarked Inflame? $13M in Q106 licensing revenue????...who would make such a blunder even in the rough draft of a PR? If it’s the PR folks, which I hope is the case, they should be fired. Its not the first time this has happened and to me it looks sloppy any way you look it.

Share
New Message
Please login to post a reply